Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer
Phase 3
Recruiting
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2024-02-02
- Target Recruit Count
- 372
- Registration Number
- NCT05159193
- Locations
- 🇨🇳
Sunyat-sen Memorial Hospital, Guandong, Guangdong, China
Outcomes of First-line Olaparib Mono-maintenance therapy-a Multicenter, Retrospective Study Using Data From Real-world Clinical Setting
- Conditions
- Ovarian Neoplasms
- Interventions
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2021-12-10
- Target Recruit Count
- 50
- Registration Number
- NCT05153603
LNK in Polycystic Ovary Syndrome With Insulin Resistance
- Conditions
- Polycystic Ovarian SyndromeInsulin Resistance
- Interventions
- Diagnostic Test: Take the patient's subcutaneous fat tissue to detect the expression of LNK
- First Posted Date
- 2021-12-06
- Last Posted Date
- 2021-12-06
- Target Recruit Count
- 80
- Registration Number
- NCT05146063
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Determination of Glycemic Index and Glycemic Load of Cereal Fiber Powder
Not Applicable
Completed
- Conditions
- Glycemic Index
- Interventions
- Dietary Supplement: Cereal powderDietary Supplement: Pure glucose powder
- First Posted Date
- 2021-12-03
- Last Posted Date
- 2021-12-03
- Target Recruit Count
- 12
- Registration Number
- NCT05143060
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma.
Phase 2
Completed
- Conditions
- Platinum-resistant Recurrent Clear Cell Ovarian Cancer
- Interventions
- First Posted Date
- 2021-11-23
- Last Posted Date
- 2023-01-31
- Target Recruit Count
- 6
- Registration Number
- NCT05130515
- Locations
- 🇨🇳
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
Neoadjuvant Sintilimab Combined With Reduction of Cycles of Chemotherapy in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma (OOC-002)
Phase 2
Recruiting
- Conditions
- Oral Cavity Squamous Cell CarcinomaOral Squamous Cell CarcinomaOropharyngeal Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2024-03-26
- Target Recruit Count
- 43
- Registration Number
- NCT05098119
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
Evaluate the Safety and Effectiveness of the Endoscopic Surgical Instrument Control System (SP1000).
Not Applicable
- Conditions
- Urologic Neoplasms
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2021-09-02
- Target Recruit Count
- 36
- Registration Number
- NCT05025930
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Nerve Sparing Versus Non Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male
- Conditions
- Bladder Cancer
- Interventions
- Procedure: nerve sparing
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2021-08-24
- Target Recruit Count
- 100
- Registration Number
- NCT05018429
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
Phase 2
Recruiting
- Conditions
- Salivary Gland Malignant NeoplasmsSalivary Gland Tumors
- Interventions
- First Posted Date
- 2021-08-11
- Last Posted Date
- 2022-12-02
- Target Recruit Count
- 15
- Registration Number
- NCT05000892
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
Phase 2
Recruiting
- Conditions
- Head and Neck Squamous Cell Carcinomas
- Interventions
- First Posted Date
- 2021-08-05
- Last Posted Date
- 2023-04-14
- Target Recruit Count
- 41
- Registration Number
- NCT04992559
- Locations
- 🇨🇳
Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China
🇨🇳Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath